Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

The food supplement improved hair growth and strength in people with a certain type of hair loss and had no major side effects.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Hair loss after weight loss surgery can improve over time.

The document suggests a possible connection between rapid weight loss and hair loss, and reports a case of skin condition improvement after stopping acne medication.

COVID-19 infection can significantly cause temporary hair loss.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Fractional and excimer lasers effectively treat various types of alopecia and promote hair growth.

The Protein-Sparing Modified Fast is effective for rapid weight loss and maintaining it, but requires medical supervision and can have side effects.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

A woman developed a severe skin reaction from the antibiotic cefalexin.

A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.